The value of carcinoembryonic antigen measurement in clinical practice.
about
Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerZizyphus spina-christi extract protects against aflatoxin B1-initiated hepatic carcinogenicity.Developments in serologic detection of human pancreatic adenocarcinoma.Diagnostic and prognostic tumor markers in the gastrointestinal tract.Clinical uses of tumor markers: a critical review.Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer.Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors.Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer?Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspectiveClinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.Carcinoembryonic antigen in anal carcinoma.Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective studyAn atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia.Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts.Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
P2860
Q27002356-87493317-489A-4B9B-A64A-29B0B818F499Q33630202-EC2EC09E-AC49-466F-8F18-6DEBE9044727Q33752171-831505C0-A59E-4112-87C9-644B3E8EFFCEQ34277292-FDED8C23-136A-4849-928A-8221DE1759E4Q34307441-9B164786-EB6C-4B6D-8AE4-DADAC568619FQ34406763-151739E9-70C9-40AB-9945-CD02243EBEBFQ37188396-CD5A3A1B-AC1A-414F-9690-9FA2347B55F2Q37200517-10CC88CB-912B-4526-AE1F-8933F0B22975Q37577659-D104F483-5AE8-4963-8B4C-81D89C33D9C1Q38052927-AE4B69A7-F1AC-467F-8246-B159D53BDE78Q38078237-636938DF-FF2D-4CEF-A4FC-0C0A2650053AQ38477014-B070DFE4-7655-45CE-BC0A-1088FA9075E6Q38649539-65C2F373-99FF-4221-B5B4-92976C58898EQ42023730-983273DC-41DA-47F8-AAAD-E055DB490167Q42050411-2B4C33B0-BE7A-4C0C-8A1B-309D2B1741AAQ42390240-F0532E12-2B46-4C4D-962C-0D1293E36547Q45869295-0373C985-7633-4BCA-968C-43725B3809A1Q46297095-8C1E0207-E13E-468E-8D04-48C527348D38Q53371627-82864EB6-B9A5-47CF-82F0-0EC50199C3A9
P2860
The value of carcinoembryonic antigen measurement in clinical practice.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The value of carcinoembryonic antigen measurement in clinical practice.
@en
type
label
The value of carcinoembryonic antigen measurement in clinical practice.
@en
prefLabel
The value of carcinoembryonic antigen measurement in clinical practice.
@en
P1476
The value of carcinoembryonic antigen measurement in clinical practice.
@en
P2093
R H Begent
P304
P356
10.1177/000456328402100401
P478
21 ( Pt 4)
P577
1984-07-01T00:00:00Z